NeurologyLive® Friday 5 — May 26, 2023

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Taking a Symptom-Based Approach to Parkinson Disease Psychosis: Aaron Ritter, MD

The director of the Memory & Cognitive Disorders Clinic at Hoag Neuroscience Institute discussed the future of treating Parkinson disease psychosis, and potential ways to lower risk of poor long-term outcomes. [WATCH TIME: 3 minutes]

2: Peer Exchange: Treatment Options for a Patient With RRMS and Psoriasis

In episode 10 of this Peer Exchange series on "The Shifting Treatment Landscape of RRMS", expert neurologists discuss treatment options for a patient with comorbid autoimmune diseases, relapsing/remitting multiple sclerosis, and psoriasis.

3: NeuroVoices: Cornelia Drees, MD, on The Advantages of Microburst Vagus Nerve Stimulation for Drug-Resistant Epilepsy

In the latest edition of our in-depth Q&A series, the senior associate consultant in the Department of Neurology at Mayo Clinic provided insight on an early feasibility study on the clinical impact of microburst vagus nerve stimulation in patients with drug-resistant epilepsy.

4: Neuro News Roundup: ALS Awarness Month

For ALS Awareness Month — May 2023 —the team has culminated some of the biggest pieces of news to offer updates on new developments in literature in ALS to spread awareness on the prevention and treatment the neuromuscular disease.

5: Importance of Stroke Awareness, Recognizing the Signs and Symptoms: Brandon Giglio, MD

The director of vascular neurology at NYU Langonediscuss stroke warning signs and prevention. He talked about the "BE-FAST” acronym and what each letter represents in terms of stroke symptoms to recognize. [WATCH TIME: 4 minutes]